3 Patents
- 0 cites
- US118063652023Modified T Lymphocytes Comprising a CD52 Antibody-inducible Caspase and Methods of Apoptosis
CELGENE CORPORATION
0 cites - US116293352023Methods of Improving Vector Transduction Efficiency Into T Lymphocytes
CELGENE CORPORATION
0 cites